...
首页> 外文期刊>BMC Neurology >Beliefs about medication as predictors of medication adherence in a prospective cohort study among persons with multiple sclerosis
【24h】

Beliefs about medication as predictors of medication adherence in a prospective cohort study among persons with multiple sclerosis

机译:关于药物治疗的信念作为药物粘附在多发性硬化症的人中药物依从性的预测因素

获取原文
           

摘要

Though adherence to disease-modifying therapies (DMTs) among persons with multiple sclerosis (PwMS) varies and is often below 80%, only few prospective studies on adherence examined predictors beyond demographic and clinical characteristics. Identify antecedents to adherence and persistence to DMT in a prospective design among PwMS. PwMS (n?=?186) were prospectively assessed at three time points: baseline, 6 (Time 1) and 12?months later (Time 2). Clinical, demographic information and patient-reported medication beliefs, illness perceptions, medication habits, perceived health and affect were surveyed in-person. Adherence and persistence were assessed by a combination of self-reports and retrospective review of medication claims. PwMS were 69.9% (Time 1) and 71% (Time 2) adherent to their DMTs and 64.5.9% were persistent. Beliefs about Medications were consistently predictive at both time points (baseline to Time 1 and Time 1 to Time 2) of medication adherence and persistence whereas other perceptions were predictive in some analyses; clinical and demographic characteristics were mostly not predictive of adherence nor persistence. The prospective association of beliefs about medication with adherence held also in multivariate analyses (OR?=?0.88, 95% CI 0.78–0.99, p?=?0.029). Adherence and persistence are predicted by medication beliefs of PwMS. As medication beliefs are modifiable, they should be assessed periodically and targeted as a focus of tailored interventions aimed to improve adherence and consequently health outcomes in PwMS. Clinical trials registry # NCT02488343 , date: 06/08/2015.
机译:虽然在多发性硬化症(PWMS)的人中依赖于疾病修饰的疗法(DMTs),但往往低于80%,但只有少数关于遵守的前瞻性研究检查了超出人口统计和临床特征的预测因子。标识中的PWM前瞻性设计前因依从性和持久性DMT。的PWM(N = 186?)在三个时间点进行前瞻性评估:基线,6(时间1)和12个月后(时间2)。临床,人口统计信息以及患者报告的药物信念,疾病认知,用药习惯,感知健康和影响进行了面对面的调查。坚持和执着,通过自我报告和用药索赔回顾性组合评估。 PWMS为69.9%(时间1)和71%(时间2)粘附于其DMT,64.5.9%持续存在。关于药物的信仰在药物遵守和持续存在的情况下,在两次时间点(基线到时间1和时间2),而其他观察在某些分析中是预测的;临床和人口统计学特征大多是不能预测,也没有坚持持久的。在多变量分析中持有的粘附性遵循的前瞻性与粘附性(或?= 0.88,95%CI 0.78-0.99,P?= 0.029)。 PWM的药物信仰预测依从性和持续性。由于药物信仰是可修改的,它们应定期评估,并针对量身定制干预措施的重点,旨在改善PWMS中的依从性和后果的健康结果。临床试验注册#NCT02488343,日期:2015年6月8日。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号